SCHEMBL10062065

SCHEMBL10062065

C#CCN[C@H](CF)Cc1ccccc1

nearest known ligand 0.62

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 3/20 0.62
CYP2D6 P10635 2/20 0.62
TSHR P16473 2/20 0.62
CYP3A4 P08684 1/20 0.62
MAOB P27338 5/20 0.50
SLC6A4 P31645 2/20 0.49
MAOA P21397 4/20 0.42
ADRA2A P08913 1/20 0.42
ADRA2B P18089 1/20 0.42
ADRA2C P18825 1/20 0.42
ADRA1A P35348 1/20 0.42
SNCA P37840 1/20 0.42
OPRK1 P41145 1/20 0.42
PKM P14618 1/20 0.42
MAPK1 P28482 1/20 0.41
KDM4E B2RXH2 1/20 0.41
SIGMAR1 Q99720 2/20 0.41
EPHX1 P07099 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3653270 0.83 CYP1A2 (0.62) CYP1A2CYP2D6TSHRCYP3A4MAOB
Desmethylselegiline SCHEMBL27813455 0.77 CYP1A2 (0.93) CYP1A2CYP2D6TSHRCYP3A4SLC6A4
Desmethylselegiline SCHEMBL4543249 0.77 CYP1A2 (1.00) CYP1A2CYP2D6TSHRCYP3A4SLC6A4
Rnordeprenyl SCHEMBL12171086 0.77 CYP1A2 (1.00) CYP1A2CYP2D6TSHRCYP3A4SLC6A4
Rnordeprenyl SCHEMBL2477570 0.77 CYP1A2 (1.00) CYP1A2CYP2D6TSHRCYP3A4SLC6A4
SCHEMBL18995778 0.76 SIGMAR1 (0.55) SLC6A4MAOASIGMAR1EPHX1
SCHEMBL10062064 0.76 SIGMAR1 (0.55) SLC6A4MAOASIGMAR1EPHX1
Rnordeprenyl SCHEMBL2473190 0.75 CYP1A2 (0.96) CYP1A2CYP2D6TSHRCYP3A4SLC6A4
Rnordeprenyl SCHEMBL29015119 0.75 CYP1A2 (0.96) CYP1A2CYP2D6TSHRCYP3A4SLC6A4
Desmethylselegiline SCHEMBL27813529 0.75 CYP1A2 (0.96) CYP1A2CYP2D6TSHRCYP3A4SLC6A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2450332-A1 Compounds for use in Imaging, diagnosing and/or treatment of diseases of the central nervous system (F-D2-Deprenyl) Bayer Pharma Aktiengesellschaft (DE) 2012-05-09 EP disclosed